Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharyn D Baker

Showing results (81-90 of 166) with videos related to

Pageof 17
Sort By:
Cancer Chemotherapy and Pharmacology|April 13, 2007
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumorsAntonio Jimeno, Michelle A Rudek, Thomas Purcell, et al.
Plos One|November 19, 2013
Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51Chengzhi Xie, Christina Drenberg, Holly Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2012
Ontogeny and sorafenib metabolismEric I Zimmerman, Justin L Roberts, Lie Li, et al.
Clinical Pharmacology and Therapeutics|July 28, 2019
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1Mingqing Chen, Claudia Neul, Elke Schaeffeler, et al.
Cancer Research|May 9, 2015
Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1bAksana Vasilyeva, Selvi Durmus, Lie Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinibNielka P van Erp, Hans Gelderblom, Mats O Karlsson, et al.
Clinical and Translational Science|September 9, 2020
DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid LeukemiaDaelynn R Buelow, Jason T Anderson, Stanley B Pounds, et al.
Molecular Cancer Therapeutics|December 14, 2002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapyClet Niyikiza, Sharyn D Baker, David E Seitz, et al.
Cancer Research|December 18, 2004
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitorsMaria L Amador, Darin Oppenheimer, Sofia Perea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2013
Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinibBrian D Furmanski, Shuiying Hu, Ken-Ichi Fujita, et al.
Pageof 17

Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
Cancer Chemotherapy and Pharmacology|April 13, 2007
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumorsAntonio Jimeno, Michelle A Rudek, Thomas Purcell, et al.
Plos One|November 19, 2013
Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51Chengzhi Xie, Christina Drenberg, Holly Edwards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2012
Ontogeny and sorafenib metabolismEric I Zimmerman, Justin L Roberts, Lie Li, et al.
Clinical Pharmacology and Therapeutics|July 28, 2019
Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1Mingqing Chen, Claudia Neul, Elke Schaeffeler, et al.
Cancer Research|May 9, 2015
Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1bAksana Vasilyeva, Selvi Durmus, Lie Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinibNielka P van Erp, Hans Gelderblom, Mats O Karlsson, et al.
Clinical and Translational Science|September 9, 2020
DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid LeukemiaDaelynn R Buelow, Jason T Anderson, Stanley B Pounds, et al.
Molecular Cancer Therapeutics|December 14, 2002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapyClet Niyikiza, Sharyn D Baker, David E Seitz, et al.
Cancer Research|December 18, 2004
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitorsMaria L Amador, Darin Oppenheimer, Sofia Perea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2013
Contribution of ABCC4-mediated gastric transport to the absorption and efficacy of dasatinibBrian D Furmanski, Shuiying Hu, Ken-Ichi Fujita, et al.
Pageof 17